ASKA Pharmaceutical Holdings Co.,Ltd.

¥2,026As of Sun 8 Nov 2026, 12:00 UTC
TSE:4886Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 2.80%
Div yield 3.21%
ROE 7.00%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.48
PE TTM 11.06
TSR TTM (0.38%)
Mkt cap ¥57.53B
ROIC 5.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,409
18.90%
(61.52%)
Hold 2|11|10|9|3
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
28.45
30.80
30.24
33.66
22.78%
19.43%
6.14%
22.61%
Revenue¥B
3.775
3.788
3.955
3.901
2.64%
0.65%
7.18%
4.66%
Peers (US$365.3M)
Cap (US$)
PE
294.9M
14.89x
Capital
TTM
5Y
10Y
Leveragex
0.421
0.170
0.152
EBIT/Intx
1.099
0.222
0.257
Own earn%
257.68
151.84
128.45
Sh yield%
57.41
15.85
15.73
Owners
Insiders/Inst%
7.35
31.19
Short interest%
4.41
SBC / revenue%
0.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
20–27
$1 testx
0.4
Incr. ROIC%
6